Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 2, 2015, Pages 67.e1-67.e7

  Mano, Roy ^a,b   Baniel, Jack ^a,b   Shoshany, Ohad ^a,b   Margel, David ^a,b   Bar On, Tomer ^c   Nativ, Ofer ^c,d   Rubinstein, Jacob ^c   Halachmi, Sarel ^c,d  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Bladder tumor; Disease progression; Lymphocyte; Neutrophil; Recurrence

Indexed keywords

BCG VACCINE; MITOMYCIN;

ADULT; AGED; ARTICLE; BLADDER IRRIGATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPHIL LYMPHOCYTE RATIO; NON MUSCLE INVASIVE BLADDER CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; SURVIVAL PREDICTION; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; DISEASE COURSE; IMMUNOLOGY; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS;

AGED; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84923565264     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.06.010     Document Type: Article

References (25)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. Babjuk M., Burger M., Zigeuner R., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013, 64:639-653.
3. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-75; [discussion 475-7].
4. Brausi M., Witjes J.A., Lamm D., et al. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol 2011, 186:2158-2167.
5. Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., Bohle A., Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008, 54:303-314.
6. Malmstrom P.U. Prognostic markers for urothelial cancer: obstacles and opportunities. Urol Oncol 2012, 30:516-517.
7. Paramanathan A., Saxena A., Morris D.L. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014, 23:31-39.
8. Roxburgh C.S., McMillan D.C. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010, 6:149-163.
9. Wei Y., Jiang Y.Z., Qian W.H. Prognostic role of NLR in urinary cancers: a meta-analysis. PLoS One 2014, 9:e92079.
10. Can C., Baseskioglu B., Yilmaz M., Colak E., Ozen A., Yenilmez A. Pretreatment parameters obtained from peripheral blood sample predicts invasiveness of bladder carcinoma. Urol Int 2012, 89:468-472.
11. Gondo T., Nakashima J., Ohno Y., et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 2012, 79:1085-1091.
12. Demirtas A., Sabur V., Akinsal E.C., et al. Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?. ScientificWorldJournal 2013, 2013:703579.
13. Krane L.S., Richards K.A., Kader A.K., Davis R., Balaji K.C., Hemal A.K. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol 2013, 27:1046-1050.
14. Ceylan C., Doluoglu O.G., Keles I., et al. Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors. Urologia 2014, 81:120-124.
15. Viers B.R., Boorjian S.A., Frank I., et al. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol 2014, doi:10.1016/j.eururo.2014.02.042. [Epub ahead of print].
16. Potretzke A., Hillman L., Wong K., et al. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder. Urol Oncol 2014, 32:631-636.
17. Budczies J., Klauschen F., Sinn B.V., et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One 2012, 7:e51862.
18. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448.
19. Sobin L.H., Wittekind C. TNM: Classification of Malignant Tumours 2002, pp xxiii. International Union against Cancer, Wiley-Liss, New York, (239 p).
20. Lamm D., Persad R., Brausi M., et al. Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. J Urol 2014, 191:20-27.
21. Azuma T., Matayoshi Y., Odani K., Sato Y., Nagase Y., Oshi M. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer 2013, 11:337-341.
22. Dalpiaz O., Ehrlich G.C., Mannweiler S., et al. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int 2013, doi:10.1111/bju.12441. [Epub ahead of print].
23. Luo H.L., Chen Y.T., Chuang Y.C., et al. Subclassification of upper urinary tract urothelial carcinoma by neutrophil to lymphocyte ratio improves prediction of oncologic outcome. BJU Int 2014, 113:E144-E149.
24. Wang L.C., Xylinas E., Kent M.T., et al. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urol Oncol 2014, 32:433-440.
25. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856.